Downloadable Slides

Share

Program Content

Activities

  • Frontline Therapy for CLL
    Selecting Initial Therapy for Patients With CLL
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 04, 2024

    Expires: December 03, 2025

  • Treating Relapsed CLL
    Considerations in Selecting Therapy for Previously Treated CLL
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 04, 2024

    Expires: December 03, 2025

  • Emerging Treatment Strategies in CLL
    A Look to the Future: Novel Agents and Combination Regimens
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 04, 2024

    Expires: December 03, 2025

Faculty

cover img faculity

Danielle M. Brander, MD

Associate Professor of Medicine
Division of Hematologic Malignancies and Cellular Therapy
Department of Medicine, Duke University
Director, CLL/Lymphoma Research
Duke Cancer Institute
Durham, North Carolina

cover img faculity

Brian Hill, MD, PhD

Director, Lymphoid Malignancies Program
Taussig Cancer Institute
Cleveland Clinic
Cleveland, Ohio

cover img faculity

Sameer A. Parikh, MBBS

Consultant, Division of Hematology
Chair, CLL Disease Team
Vice Chair, Lymphoid Malignancies Disease Group
Mayo Clinic Comprehensive Cancer Center
Associate Professor of Medicine
Assistant Professor of Oncology
Mayo Clinic
Rochester, Minnesota

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC.

Supporters

Supported by educational grants from AstraZeneca, BeiGene, and Lilly.

AstraZeneca

BeiGene

Lilly

Partners

Clinical Care Options, LLC

ProCE Banner